期刊文献+

不稳定型心绞痛患者血清Hcy和sFas的水平及相关分析

Study on the Relationship Between Serum Hcy and Soluble Fas Levels in Patients with Unstable Angina Pectoris
下载PDF
导出
摘要 目的:探讨不稳定型心绞痛(unstable angina pectoris,UAP)患者血清Hcy水平的变化和可溶性Fas(sFas)水平的相关性。方法:应用酶联免疫吸附法(ELISA)对60例UAP患者进行了血清Hcy和血清sFas检测并与40例正常健康人做比较。结果:危险分层为Ⅱ、Ⅲ级的UAP患者血清Hcy与sFas水平非常显著地高于正常对照组(P<0.01);组间比较,危险分级Ⅱ、Ⅲ级UAP患者血清Hcy与sFas水平明显高于危险分级Ⅰ级组;UAP患者血清Hcy水平与sFas水平呈明显正相关(r=0.586,P<0.01)。结论:高水平的血清Hcy和sFas与UAP有关,可能通过细胞凋亡和炎症反应途径参与冠状动脉粥样硬化斑块的发生发展。 Objective To study the relationship between changes of serum Hcy and soluble Fas(sFas) levels in patients with unstable angina pectoris.Methods Serum Hcy and sFas(with ELISA) levels were measured in 60 patients with UAP(every stage of Ⅰ,Ⅱ,Ⅲ: 20 patients) and 40 controls.Results Levels of serum Hcy and sFas were significantly higher in the patients of Ⅱ,Ⅲ stage of UAP than those in controls(P0.01),in the same group,the levels of serum Hcy and sFas were obviously higher in the Ⅱ,Ⅲ stage of UAP than that in I stage of UAP,These two variables were significantly positively correlated(r=0.586,P0.01).Conclusion High levels of Hcy and sFas have relationship with UAP.They may be contribute to the development of atherosclerotic plaque by cell apoptosis and inflammatory response.
出处 《放射免疫学杂志》 CAS 2011年第2期161-163,共3页 Journal of Radioimmanology
关键词 不稳定型心绞痛 同型半胱氨酸 可溶性Fas(sFas) unstable angina pectoris(UAP) homocystein(Hcy) soluble Fas(sFas)
  • 相关文献

参考文献8

  • 1Hansson GK.Immune mechanisms in atherosclerosis[J].Artherioscler Thromb Vasc Biol,2001,21:1876-1890.
  • 2Anderson JL,Adams CD,Antman EM,et al.ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction[J].J Am Coll Cardiol,2007,50(7):1-157.
  • 3王吉耀.内科学[M].北京:人民卫生出版社.2006年第1版:459.
  • 4Mendis S,Ranatunga P.Heperhomocysteinaemia in srilandkan patients with coronary artery disease[J].Ceylon Med J,2002,47(3):89-92.
  • 5Boyle JJ,Bowyer DE,Weissberg PL,et al.Human blood derived macrophage induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Jas interactions[J].Arterioscler Thromb Vasc Biol,2001,21:1402-1407.
  • 6董玉江.血清可溶性Fas及炎性因子与冠心病不同表型的临床相关性研究[J].山东医学高等专科学校学报,2007,29(6):457-461. 被引量:2
  • 7胡司淦,蔡鑫,包宗明,高大胜,张恒,史晓俊.冠心病患者血清可溶性Fas和TNF-α水平变化[J].中国心血管病研究,2006,4(2):133-135. 被引量:7
  • 8葛长江,胡申江,郑霞,陈治奎,孙坚,武垚森.冠心病患者血清sFas和sFasL及sIL-2R的水平[J].浙江大学学报(医学版),2002,31(5):337-339. 被引量:12

二级参考文献36

  • 1李崇剑,高润霖,杨跃进,陈纪林.易损斑块的病理生理机制及其检测的研究进展[J].中华心血管病杂志,2004,32(6):570-573. 被引量:88
  • 2朱锡华.Fas系统研究进展[J].中华微生物学和免疫学杂志,1996,16(2):77-82. 被引量:39
  • 3[1]Hansson GK.Immune mechanisms in atherosclerosis.Artherioscler Thromb Vasc Biol,2001,21:1876-1890.
  • 4[2]Stoneman VEA,Bennett MR.Role of apoptosis in atherosclerosis and its therapeutic implications.Clin Sci,2004,107:343-354.
  • 5[3]Frostegard J,Ulfgren AK,Nyberg P,et al.Cytokine expression in advanced human atherosclerotic plaques:dominance of pro-inflammatory (Th1) and macrophage stimulating cytokines.Atherosclerosis,1999,145:33-45.
  • 6[4]Bennett MR.Apoptosis in the cardiovascular system.Heart,2002,87:480-487.
  • 7[5]Jeremias I,Kupatt C,Martin Villalba A,et al.Involvement of CD95/Apo-1/Fas in cell death after myocardial ischemia.Circulation,2000,102:915-920.
  • 8[6]Elahi AW,Vijayakumar AN,Lichstein E,et al.Interplay of antibody and T cell response in acute myocardial infarction.J Lab Clin Med,2001,138:112-118.
  • 9[7]Rubin LA,Nelson DL.The soluble interleukin-2 receptor:Biology,function,and clinical application.Ann Intern Med,1990,113:619-627.
  • 10[9]Boyle JJ,Bowyer DE,Weissberg PL,et al.Human bloodderived macrophage induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-Ligand/Fas interactions.Arterioscler Thromb Vasc Biol,2001,21:1402-1407.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部